Effect of Unani herbal medicine in irregular menses

Effect of Unani formulation versus Metformin on Menstrual Regulation in women with polycystic ovarian syndrome: A randomized standard controlled trial. - nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/12/099522

Enrollment

Registered

2025-12-19

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

Intervention1: Unani formulation parsiyawshan (Adinatus capillus linn) Post-e-khayareshambar (Casia fistula) Mushktramashi (Mentha longifolia) Qand siyah (Saccharum officinarum linn): Mushkrtamashi

Eligibility

Inclusion criteria

Inclusion criteria: Fulfilling Rotterdams criteria 1 clinical hyperandrogenism or biochemical hyperandrogenism 2 evidence of oligomenorrhea or amenorrhea 3 polycystic appearing ovarian morphology on ultrasound

Exclusion criteria

Exclusion criteria: 1 Pregnant and lactating women 2 Patients on hormonal contraceptives use within 3 months 3 Patients with history of malignancies or endometrial tuberculosis or uterine fibroid other ovarian cyst 4 Participants with uncontrolled HTN DM Thyroid disorder

Design outcomes

Primary

Measure	Time frame
Menstrual regulationTimepoint: 3 months	—

Secondary

Measure	Time frame
Change in ovarian volume Modified Ferriman Gallwey score Acanthosis nigricans SF 12 QOL BMI Timepoint: 3 months	—

Countries

India

Contacts

Public ContactWajeeha Begum

National institute of unani medicine

drwajeehanium@gmail.com9972550185

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026